Document is current

Any future updates will be listed below

Nipocalimab reduces Sjögren disease activity in phase II trial

Crossref DOI link: https://doi.org/10.1038/s41584-025-01334-6

Published Online: 2025-11-24

Published Print: 2026-01

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark